Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. (SHE:301584)
China · Delayed Price · Currency is CNY 22.45
+0.66 (3.03%)
Jun 24, 2026, 4:00 PM EDT
SHE:301584 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 269.63 | 228.31 | 196.3 | 174.28 | 166.94 |
Depreciation & Amortization | 91.54 | 82.7 | 57.7 | 38.99 | 29.05 |
Other Amortization | 32.02 | 21.86 | 12.81 | 5.96 | 4.32 |
Loss (Gain) From Sale of Assets | -2.12 | -0.49 | -0.23 | -0.33 | 0.03 |
Asset Writedown & Restructuring Costs | 103.54 | 0 | 0.28 | - | 18.25 |
Loss (Gain) From Sale of Investments | -0.45 | - | - | -0.73 | - |
Provision & Write-off of Bad Debts | - | 14.45 | 9.36 | 31.06 | 13.95 |
Other Operating Activities | 200.39 | 237.45 | 199.13 | 116.27 | 47.44 |
Change in Accounts Receivable | -1,550 | -752.03 | -744.35 | -351.09 | 275.23 |
Change in Inventory | -26.91 | -1,000 | -719.35 | -631.22 | -756.46 |
Change in Accounts Payable | 1,647 | 1,340 | 612.83 | 6.73 | -515.74 |
Change in Other Net Operating Assets | 5.42 | 1.39 | 3.48 | 3.81 | - |
Operating Cash Flow | 748.31 | 164.48 | -374.57 | -627.89 | -732.97 |
Operating Cash Flow Growth | 354.96% | - | - | - | - |
Capital Expenditures | -80.71 | -121.05 | -82.39 | -33.5 | -10.18 |
Sale of Property, Plant & Equipment | 4.59 | 0.74 | 0.05 | 0.03 | 0.06 |
Cash Acquisitions | - | - | -11.94 | - | - |
Investment in Securities | -76.38 | - | - | - | - |
Other Investing Activities | -2.39 | - | - | -8.11 | - |
Investing Cash Flow | -154.88 | -120.31 | -94.28 | -41.58 | -10.12 |
Long-Term Debt Issued | 4,148 | 4,457 | 4,274 | 2,873 | 1,807 |
Long-Term Debt Repaid | -4,866 | -4,178 | -3,181 | -1,592 | -688 |
Net Debt Issued (Repaid) | -717.99 | 278.85 | 1,093 | 1,280 | 1,119 |
Issuance of Common Stock | 443 | - | - | - | - |
Common Dividends Paid | -156.78 | -151.89 | -133.61 | -142.35 | -149.11 |
Other Financing Activities | -106.27 | -3.17 | -47 | -24.88 | -364.85 |
Financing Cash Flow | -538.04 | 123.8 | 912.43 | 1,113 | 604.97 |
Foreign Exchange Rate Adjustments | 0 | 0 | -0 | -0.01 | 0.01 |
Miscellaneous Cash Flow Adjustments | - | 0 | -0 | -0 | - |
Net Cash Flow | 55.39 | 167.96 | 443.58 | 443.65 | -138.12 |
Free Cash Flow | 667.6 | 43.42 | -456.96 | -661.39 | -743.15 |
Free Cash Flow Growth | 1437.49% | - | - | - | - |
Free Cash Flow Margin | 3.44% | 0.24% | -2.96% | -5.57% | -7.41% |
Free Cash Flow Per Share | 1.76 | 0.12 | -1.28 | -1.86 | -2.09 |
Cash Income Tax Paid | - | 266.04 | 234.46 | 162.48 | 158.27 |
Levered Free Cash Flow | 259.71 | -14.76 | -627.38 | -671.36 | -806.67 |
Unlevered Free Cash Flow | 342.38 | 86.49 | -544.33 | -622.62 | -782.7 |
Change in Working Capital | 53.76 | -419.81 | -849.92 | -993.4 | -1,013 |